Human 3 -hydroxysteroid dehydrogenase/steroid 5 -4 -isomerase (3 -HSD/isomerase) is a bifunctional, single enzyme protein that is membranebound in the endoplasmic reticulum (microsomes) and mitochondria of cells in the placenta (type I) and in the adrenals and gonads (type II). Two membrane-binding domains (residues 72-89 and 283-310) have been predicted by analyses of hydrophobicity in the type I and II isoenzymes (90% regional homology). These putative membrane domains were deleted in the cDNA by PCR-based mutagenesis, and the two mutant enzymes were expressed by baculovirus in insect Sf9 cells. Differential centrifugation of the Sf9 cell homogenate containing the 283-310 deletion mutant revealed that 94% of the 3 -HSD and isomerase activities were in the cell cytosol, 6% of the activities were in the microsomes, and no activity was in the mitochondria. This is the opposite of the subcellular distribution of the wild-type enzyme with 94% of the activities in the microsomes and mitochondria and only 6% activity in the cytosol. The organelle distribution of the 72-89 deletion mutant lies between these two extremes with 72% of the enzyme activity in the cytosol and 28% in the microsomes/ mitochondria. The integrity of the subcellular organelle preparations was confirmed by electron microscopy. Western immunoblots confirmed the presence of the 283-310 deletion mutant enzyme and the absence of the wild-type enzyme in the insect cell cytosol. The unpurified, cytosolic 383-310 deletion mutant exhibited 3 -HSD (22 nmol/min per mg) and isomerase (33 nmol/min per mg) specific activities that were comparable with those of the membrane-bound, wild-type enzyme. The isomerase reaction of the cytosolic 283-311 deletion mutant requires activation by NADH just like the isomerase of the microsomal or mitochondrial wild-type enzyme. In contrast, the 72-89 deletion mutant had low 3 -HSD and isomerase specific activities that were only 12% of the wild-type levels. This innovative study identifies the 283-310 region as the critical membrane domain of 3 -HSD/isomerase that can be deleted without compromising enzyme function. The shorter 72-89 region is also a membrane domain, but deletion of this NH 2 -terminal region markedly diminishes the enzyme activities. Purification of the active, cytosolic 283-310 deletion mutant will produce a valuable tool for crystallographic studies that may ultimately determine the tertiary/ quaternary structure of this key steroidogenic enzyme.
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INTRODUCTION
Human placental 3 -hydroxysteroid dehydrogenase (3 -HSD, EC 1·1·1·145) and steroid 5 -4 -isomerase (EC 5·3·3·1) catalyze the sequential conversion of 3 -hydroxy-5-ene steroids (pregnenolone and dehydroepiandrosterone (DHEA)) to 3-oxo-4-ene steroids (progesterone and androstenedione) on a single, dimeric protein containing both enzyme activities . The bifunctional enzyme catalyzes a key biosynthetic step that is required for each of the pathways that produce active steroid hormones. In the human, the type I enzyme (placenta, skin and mammary gland) and the type II enzyme (gonads and adrenals) are expressed in a tissue-specific pattern, are encoded by two distinct genes, and have 93% homology in amino acid sequences (Simard et al. 1996) . The 3 -HSD and isomerase activities co-purify as a single protein from human term placenta (Thomas et al. 1988 and from Spodoptera fungiperda (Sf9) insect cells infected with the human type I or type II recombinant baculovirus (Nash et al. 1994 , Zhou et al. 1996 . 3 -HSD/isomerase is a membrane-bound enzyme that resides in the endoplasmic reticulum and mitochondria of the cells of mammalian steroidogenic tissues , Cherradi et al. 1995 . The protein contains no NH 2 -terminal targeting sequence that determines the subcellular localization of the enzyme (Luu-The et al. 1989) . Two regions in the primary enzyme structure have been predicted by hydrophobicity analyses to be membrane-spanning domains in 15 of the deduced proteins from the 3 -HSD gene family (Simard et al. 1996) . One hydrophobic segment lies in the NH 2 -terminal region (residues 72-89), and the other segment is in the COOH-terminal region (residues 283-310) of both the human type I (Fig. 1) and type II enzymes. Each predicted membraneanchoring region has been deleted to produce the mutant cDNA that encodes the enzyme lacking one of the two segments. These cDNA molecules have been introduced into recombinant baculovirus for expression in eukaryotic Sf9 cells, which have subcellular organelle structures that are identical to mammalian cells (Green et al. 1996 , Gough et al. 1998 . After differential ultracentrifugation, the distribution of the two mutant enzymes and the wild-type enzyme among the endoplasmic reticulum (microsomes), mitochondria and cytosol has been determined. The activity profiles measured for the deletion mutant enzymes relate the importance of each membrane domain to enzyme function.
In addition to characterizing the membranespanning domains of 3 -HSD/isomerase, these innovative experiments have created a cytosolic form of the enzyme that possesses 3 -HSD and isomerase activities comparable with those of the wild-type enzyme. The presence of the detergents needed to solubilize the enzyme from microsomes and mitochondria , Zhuo et al. 1996 has prevented the structural analysis of this important steroidogenic enzyme. The development  1. Amino acid sequence of human type I 3 -HSD/isomerase showing the predicted membrane-spanning regions (underlined). His 261 and Tyr 253 have been shown to be active site residues by mutagenesis (Thomas et al. 1998) .
of a fully active, cytosolic form of the enzyme that can be purified without using detergents provides a useful tool for future crystallographic studies.
MATERIALS AND METHODS

Materials
Pregnenolone, DHEA and pyridine nucleotides were purchased from Sigma Chemical Co. (St Louis, MO, USA); 5-androstene-3,17-dione and 5-pregnene-3,20-dione from Steraloids Inc. (Wilton, NH, USA); reagent grade salts, chemicals and analytical grade solvents from Fisher Scientific Co. (Pittsburg, PA, USA). Glass distilled, deionized water was used for all aqueous solutions.
Site-directed mutagenesis
The 1555 bp cDNA that encodes human type I (placental) 3 -HSD/isomerase was cut from the host plasmid, pCMV5H3 HSD, using EcoR1/PspA1 and ligated into pGEM-3Z (Promega Corporation, Madison, WI, USA) to produce pGEM-3 HSD (Nash et al. 1994) . A double-stranded PCR method of site-directed mutagenesis (Weiner et al. 1994 , Chau et al. 1997 produced the mutant cDNA from the pGEM-3 HSD template (4298 bp) using the high-fidelity Klentaq DNA polymerase (supplied by W Barnes, Washington University, St Louis, MO, USA). The forward primer, 5 -GTCACTCACAG AGAGTCTATCATGAA-3 , and the abutting reverse primer, 5 -GGCTCTCTTCAGGAATGG CTCATC-3 , were used to create the mutant 3 -HSD cDNA with the codons deleted for amino acids 72-89 ( Fig. 1 ). This truncated protein is hereafter referred to as the 72-89 deletion mutant. The forward mutated primer, 5 -CGACCGCCCT TCAACCGCCAC-3 , and the abutting reverse primer, 5 -TCTGGAATCAAGGCGGAGGCCG-3 , were used to create the mutant 3 -HSD cDNA with the codons deleted for amino acids 283-310 ( Fig. 1 ). This truncated protein is hereafter referred to as the 283-310 deletion mutant. The correct mutations were confirmed using a PCR-based dideoxynucleotide sequencing method (Thermo Sequenase kit, Amersham Life Science, Cleveland, OH, USA). In addition, the cDNA encoding each mutant protein was sequenced to confirm its integrity.
Expression of the mutant and wild-type enzymes
The mutant 3 -HSD cDNA was cut from pGEM-3 HSD using EcoR1/PspA1 and ligated into the baculovirus transfer vector pVL1392 (Invitrogen, San Diego, CA, USA). The recombinant baculovirus was produced by transfecting Sf9 cells with linearized AcMNPV DNA and the pVL1392-3 HSD using the Invitrogen Bac-N-Blue transfection kit. Screening for the recombinant baculovirus by plaque assay and infection of Sf9 cells were performed as previously described for the wild-type 3 -HSD/isomerase (Nash et al. 1994) . Baculoviral stock was added to 1 10 7 Sf9 cells at a multiplicity of infection (m.o.i.) of 10 for expression of the wild-type, 283-310 deletion mutant or 72-89 deletion mutant enzymes. Each form of 3 -HSD/ isomerase was expressed for 72 h in suspension cultures of Sf9 cells.
Preparation of subcellular fractions
Each recombinant baculovirus-infected Sf9 cell suspension (500 ml) was homogenized with a hand-held, fritted glass homogenizer in 25 ml 0·01 M potassium phosphate buffer, pH 7·4. The homogenate was centrifuged at 800 g for 30 min in a Beckman (Fullerton, CA, USA) L8-M ultracentrifuge to pellet cell debris and nuclei. The supernatant was centrifuged at 10 000 g to pellet the mitochondria. The resulting supernatant was centrifuged at 110 000 g to obtain the microsomes. The 110 000 g supernatant contained the Sf9 cell cytosol. The mitochondrial and microsomal pellets were resuspended in 0·02 M potassium phosphate buffer, pH 7·4, and centrifuged at 10 000 g and 110 000 g, respectively, to obtain washed organelle preparations. Protein concentrations were determined by the Coomassie Blue method using BSA as standard (Bradford 1976) .
The mitochondrial and microsomal pellets were examined by electron microscopy. The pellets were fixed in 1% glutaraldehyde and treated with 1·25% osmium tetroxide. The pellets were embedded in Polybed 812 resin (Polysciences Inc., Warrington, PA, USA). Sections were stained with uranyl acetate/lead acetate and examined in a Zeiss 902 electron microscope (Leo Electron Microscopy, Thornwood, NY, USA).
The activities of the mitochondrial marker enzyme, succinic-cytochrome c reductase (Tisdale 1967) , and of the microsomal marker enzyme, triphosphopyridine nucleotide-cytochrome c reductase (Phillips & Langdon 1962) , were measured using the published methods.
Western blots
The expressed enzyme was separated by SDS-polyacrylamide (7·5%) gel electrophoresis, electroblotted onto a nitrocellulose membrane, probed with primary antibody raised against human placental 3 -HSD/isomerase, and incubated with 125 I-labeled goat anti-rabbit IgG (1·0 µCi, ICN Biomedicals, Irvine, CA, USA) as described previously for the wild-type enzyme (Nash et al. 1994) . The immunoreactive bands were visualized using a Molecular Dynamics (Sunnyvale, CA, USA) Model 400 PhosphorImager.
Enzyme assays
The 3 -HSD activity of each organelle preparation was measured in incubations containing 5 -androstan-3 -ol-17-one (50 µM), NAD + (200 µM) and protein (80 µg) at 22 C in 0·05 M glycineNaOH, pH 9·7. When measuring 3 -HSD activity in cell homogenates and organelle preparations, the use of the 3 -hydroxy-5 -reduced substrate steroid at the pH optimum (9·7) provides a more accurate, reproducible spectrophotometric assay at 340 nm (<5% variation between duplicate assays) compared with an assay that uses DHEA as substrate (Milevich et al. 1993 , Nash et al. 1994 . The slope of the initial linear increase in absorbance at 340 nm (due to NADH production) per unit time was used to determine 3 -HSD activity.
The isomerase activity of each organelle was determined in incubations of 5-androstene-3,17-dione (50 µM), NADH (0·05 mM), and protein (40 µg) at 22 C in 0·02 M potassium phosphate buffer, pH 7·5. Isomerase activity was measured by the initial absorbance increase at 241 nm (due to androstenedione formation) as a function of time. Blank assays (zero enzyme, zero substrate) ensured that specific isomerase activity was measured as opposed to non-enzymatic, 'spontaneous' isomerization (Thomas et al. 1988) . Changes in absorbance were measured with a Varian (Sugar Land, TX, USA) Cary 219 recording spectrophotometer.
RESULTS
Electron microscopy and marker enzymes verify the integrity of the subcellular organelles
The mitochondrial fraction obtained from the Sf9 cells infected with baculovirus containing the wild-type cDNA is shown in Fig. 2A . Mitochondria are present in this washed 800-10 000 g pellet, and there is minimal contamination by microsomes. The microsomal fraction (the washed 10 000-110 000 g pellet) from the same Sf9 cell homogenate contains numerous microsomes of various sizes, and mitochondria are not visible (Fig. 2B) . The specific activity of succinic-cytochrome c reductase in the mitochondrial preparation (210 nmol/min per mg) is 10·5-fold higher than in the microsomal preparation (20 nmol/min per mg). The triphosphopyridine nucleotide-cytochrome c reductase in the microsomal preparation (190 nmol/min per mg) is 12·6-fold greater than in the mitochondrial preparation (15 nmol/min per mg). The cytosol has no detected activity of either marker enzyme. Thus, cross-contamination among our organelle preparations is less than 10%.
Western immunoblots
As shown in Fig. 3 , the wild-type and the two deletion mutant proteins were expressed in homogenates of the baculovirus-infected Sf9 cells. Western immunoblots were also performed on the subcellular fractions of the Sf9 cells that expressed each of the three forms of 3 -HSD/ isomerase (Fig. 4) . The absence of an immunoreactive band in lane 2 (cytosol) with strong bands in lane 3 (microsomes) and lane 4 (mitochondria) indicates that the wild-type enzyme is localized in the membranes of the two subcellular organelles and not in the cytosol. In contrast, the band in lane 5 shows the presence of the 283-310 deletion mutant enzyme in the cytosol and the microsomes (lane 6) with only a hint of this protein in the 
mitochondria (lane 7)
. By increasing the loaded protein to 40 µg from 10 µg, the presence of the 72-89 deletion mutant enzyme could be detected in the cytosol (lane 8), microsomes (lane 9) and mitochondria (lane 10). Because an excess of each organelle protein was loaded on the gel, these results are qualitative (not quantitative) and primarily show that the deletion of the 283-310 domain produces a form of 3 -HSD/isomerase that is localized in the cell cytosol.
Enzyme activities in the subcellular fractions
To quantify the distribution of the wild-type and deletion mutant enzymes among the Sf9 organelles, the 3 -HSD and isomerase activities were independently measured using our spectrophotometric assays. These assays allow the separate measurement of the two activities as opposed to a radioactive assay that measures the two-step conversion of [ 3 H]DHEA to [ 3 H]androstenedione. Thus, the effects of the deleted membrane domain on each activity can be evaluated.
As shown in Table 1 , the total 3 -HSD activity of the wild-type I enzyme is distributed between the microsomes and mitochondria of the Sf9 cells with very little activity in the Sf9 cell cytosol. This subcellular distribution in Sf9 cells is similar to that of the human placental enzyme in trophoblast cells (Thomas et al. 1988 . When amino acid residues 283-310 in the larger of the two hydrophobic domains are deleted and the 72-89 region remains, the 3 -HSD activity of the mutant protein is localized predominantly (94·5%) in the cytosol (Table 1 ). The specific 3 -HSD activity of the 283-310 deletion mutant in the cell homogenate and cytosol is slightly higher than the specific 3 -HSD activity measured for the wild-type enzyme. When amino acid residues 72-89 in the smaller hydrophobic domain are deleted and the 283-310 region remains, a significant portion of the total 3 -HSD activity resides in the microsomes and mitochondria (28·2%), and the majority (71·8%) of the total activity is in the cytosol (Table 1) . However, the specific 3 -HSD activity of the 72-89 deletion mutant is 8-fold lower than the wild-type 3 -HSD activity.
The subcellular distributions for the total isomerase activity of the 283-310 deletion mutant, wild-type and 72-89 deletion mutant (Table 2) are the same as those measured for the 3 -HSD activity. Similar to the relative 3 -HSD activities, the 283-310 deletion mutant has a specific isomerase activity that is slightly higher than that of the wild-type, and the 72-89 deletion mutant has an 8-fold lower specific isomerase activity. The isomerase reaction of the cytosolic 283-311 deletion mutant requires activation by NADH just like the isomerase of the microsomal or mitochondrial wild-type enzyme. In each case, the omission of NADH from the assay mixture results in the inability to detect any isomerase activity.
DISCUSSION
Because 3 -HSD/isomerase lacks a targeting sequence that directs the translated protein to specific organelles (Luu-The et al. 1989) , the two hydrophobic domains in the membrane-bound enzyme may be critical for subcellular localization. In this study, we have deleted each of the putative membrane-spanning domains to determine their importance to subcellular distribution and enzyme activity. The human wild-type I (placental) enzyme is localized mainly in the endoplasmic reticulum with a smaller, but significant, portion in the mitochondria and virtually none in the Sf9 cell cytoplasm (Tables 1 and 2) .
We chose to delete the hydrophobic domains instead of substituting polar amino acids for  1. The 3 -HSD activities of the mutant enzyme proteins with deleted membrane domains are compared with those of the wild-type enzyme after subcellular fractionation. The organelles were obtained from the homogenate of a baculovirus-infected Sf9 cell suspension (500 ml) using standard ultracentrifugation techniques. The 3 -HSD activity of each Sf9 cell fraction was determined by spectrophotometric assay at 340 nm in incubations of 5 -androstan-3 -ol-17-one (50·0 µM), NAD + (0·2 mM) and cellular protein (0·08 mg) in 0·05 M glycine-NaOH, pH 9·7. Total activity for the subcellular fractions was calculated by multiplying the specific activity times the total mg protein in each organelle preparation. The percent of total activity (in parentheses) was determined by: (total activity in each organelle)/(sum of the three organelle activities) 100  2. The isomerase activities of the mutant enzyme proteins with deleted membrane domains are compared with those of the wild-type enzyme after subcellular fractionation. The isomerase activity of each Sf9 cell fraction was determined by spectrophotometric assay at 241 nm in incubations of 5-androstene-3,17-dione (50·0 µM), NADH (0·05 mM) and cellular protein (0·04 mg) in 0·02 M potassium phosphate buffer, pH 7·4. These are the same Sf9 cells and organelles used in non-polar residues as previously reported for rat 3 -HSD/isomerase (Simard et al. 1991) . Although the introduction of multiple polar residues decreases the hydrophobicity of the domain, there is a good chance that conformational changes in the protein structure would have destroyed the enzyme activities. Since the creation of an active, cytosolic form of the enzyme was a goal of this study, each of the two hydrophobic regions was deleted separately.
The positive results obtained for the 283-310 deletion mutant indicate that we made the correct choice.
The deletion of amino acid residues 283-310 in the COOH-terminal hydrophobic domain of 3 -HSD/isomerase produces a mutant enzyme that is cytosolic and yet retains the full 3 -HSD and isomerase activities. Thus, the 283-310 region is the critical membrane-spanning domain and is not essential for either enzyme activity. The presence of the 72-89 hydrophobic domain in the 283-310 deletion mutant accounts for a small percentage (5·5%) of the enzyme being retained in the microsomes, while none is detected in the mitochondria.
Deletion of residues 72-89 in the NH 2 -terminal region produces a mutant protein that is distributed among the microsomes, mitochondria and cytosol. Because 28% of the 3 -HSD and isomerase activities remain in the membranes of microsomes and mitochondria, the presence of the 283-310 domain in this mutant allows the protein to retain significant hydrophobicity. However, a majority (72%) of the protein is shifted into the cytosol, so the 72-89 region does contribute to membrane association. The 8-fold loss of both 3 -HSD and isomerase activity that results from the 72-89 deletion underscores the importance of this region to enzyme function. Our data obtained with the human type I enzyme are consistent with a previous study in which the increased polarity of the domain between residues 75 and 91 in rat type II 3 -HSD/isomerase was responsible for its having much lower activity than the rat type I enzyme (Simard et al. 1991) . Thus, the presence of this highly conserved hydrophobic domain may be crucial to activity in the entire 3 -HSD gene family.
Despite our procedures that ensured a high viral titer of the recombinant baculovirus containing the gene for the 72-89 deletion mutant, the intensity of the protein band in the Western blots was low compared with the protein bands obtained for the same amount of the wild-type and 283-310 deletion mutant. This suggests that the 72-89 domain is recognized as one of the epitopes by our polyclonal antibody.
In addition to assessing the role of each hydrophobic region in membrane association and activity, this study has produced an exciting result that may have an impact on the structural study of 3 -HSD/isomerase. Retention of the full 3 -HSD and isomerase activities by the cytosolic 283-310 deletion mutant indicates that the enzyme maintains its active tertiary/quaternary structure when the protein lacks residues 283-310. The conformational integrity of the 283-310 deletion mutant is supported because NADH allosterically activates the isomerase activity of the mutant in the same manner that was demonstrated for the wild-type enzyme (Thomas et al. 1995 ). An active, cytosolic form of the enzyme does not support the need for a proper phospholipid, membrane environment, which was suggested by studies in which treatment with phospholipase A inactivated microsomal and mitochondrial 3 -HSD (Ferre et al. 1975) .
Because the wild-type enzyme from all tissues and species is membrane-bound, it is necessary to solubilize the enzyme from the microsomes or mitochondria using detergent as the first step in purification (Thomas et al. 1988 , Zhou et al. 1996 . Detergent must be included in the buffers during the purification, and removal of detergent from the purified preparation leads to the amorphous precipitation of inactive enzyme protein (our observation). This dependence on detergent for solubility is most likely the reason that purified 3 -HSD/isomerase has not been successfully crystallized. Purification of the fully active 283-310 deletion mutant from the Sf9 cell cytosol should produce a homogeneous, detergentfree enzyme that is more amenable to crystallization. A new purification scheme must be developed to replace the detergent-based procedure. Because 3 -HSD/isomerase is too large (dimeric molecular mass 84 000 Da) for structural analysis by nuclear magnetic resonance, the creation of this cytosolic form of the enzyme provides an important tool that may ultimately reveal the three-dimensional structure of this key steroidogenic enzyme. It will then be possible to localize amino acids that have been shown to be critical for activity by mutagenesis (e.g. His 261 , Tyr 253 in Thomas et al. 1998) in the tertiary/ quaternary structure of human type I 3 -HSD/ isomerase. Because the 3 -HSD/isomerase type I gene is selectively induced by interleukin-4 and -13 in several human breast tumor cell lines (Gingras et al. 1999) , characterization of the structure/function relationships of the reaction mechanisms for the type I enzyme has substantial clinical significance.
